Privacy Policy
Signals Blog

Contributors

Categories

Right Turn: “Comic” twist on CRISPR

There’s nothing really funny about the patent debate on CRISPR-Cas9 gene editing. It’s been a contentious and expensive court battle, that has thankfully steered clear of mud-slinging (mostly). Which is good, since there’s more than enough of that in the U.S. these...

A new style of MSC immunotherapy – Instructions included

If you have been following stem cell news lately, you know that there have been several recent Food and Drug Administration (FDA) meetings regarding how to classify stem cells, which ultimately affects if and how they will be regulated. There are many medical...

Right Turn: Hope for patients suffering from sepsis

September is Sepsis Awareness Month and World Sepsis Day was acknowledged earlier this week – on Tuesday, September 13. That’s why there’s a good possibility that you have seen the video below, about a heartbroken mother who lost her young son to sepsis. (It has...

Right Turn: Has cancer immunotherapy arrived?

It was Science magazine’s 2013 breakthrough of the year and called a “turning point in cancer.” It even scored its own awareness month that year. Cancer immunotherapy – therapies that harness the power of a patient’s immune system to fight their disease – had...